What are the latest recommendations on the use of aspirin in the primary prevention of cardiovascular disease?
As described below, the recommendations for the secondary prevention (in people who already have had a heart attack or stroke) of future attacks are more compelling. In 2009, the U.S. Preventive Services Task Force (USPSTF) has come up with slightly modified recommendations for the primary prevention of cardiovascular disease using aspirin. Based on their review of the published data: • They encourage the use of aspirin in men between 45-79 years of age and women between 55-79. • In individuals older than 80, the treatment with aspirin was associated with more bleeding episodes which outweigh the protective benefits. • In men younger than 45 and women younger than 55, the benefits of aspirin seemed to too insignificant to warrant routine use for the prevention of cardiovascular disease. What is the optimal dose of aspirin for treating and preventing heart attacks and strokes? An ideal dose of aspirin is one that maximizes its benefits but minimizes side effects. However, the ideal dose
Related Questions
- Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease?
- Does Contemporary Trial Evidence Support the Routine Use of Aspirin in Primary Prevention of Heart Disease?
- What is the optimum dose of aspirin for long-term prevention of cardiovascular disease?
